N-(2,4,6-Trifluorobenzyl)piperidin-4-amine dihydrochloride, 1g

4-Cyclopropyl-1H-pyrazol-3-amine, 95.0%, 5g

(AC-CYS-OH)2, 90.0%, 100mg

Microliter syringe MICROLITER® series 7000 Point type 2, 1.0 µl, 7001 KH, 1 piece

7-Methyl-2,5,7-triazaspiro[3.4]octane-6,8-dione hydrochloride, 97%, 100mg

4-Naphthalen-1-ylaniline, 97%, 10g

4-(2-((ethylthio)methyl)pyrrolidin-1-yl)piperidine, 95.0%, 250mg

1-Piperidinyloxy, 4-amino-4-carboxy-2,2,6,6-tetramethyl-, 95%, 10mg

2,2-Bis(3-amino-4-hydroxyphenyl)-hexafluoropropane, 98.0%, 100g

ethyl (benzylamino)(oxo)acetate, 95.0%, 100mg

1,2-Dimethyl-4-(pentafluoroethyl)benzene, 98.0%, 1g

5-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]-3-PYRIDINECARBALDEHYDE, 95%, 1g

(R)-7-(But-2-ynyl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione, 98%, 5g